Leveraging therapeutic potential of multi-targeted siRNA inhibitors.
about
Fighting against kidney diseases with small interfering RNA: opportunities and challengesRNAi2013: RNAi at OxfordInhibition of porcine endogenous retrovirus in PK15 cell line by efficient multitargeting RNA interference.The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity.
P2860
Leveraging therapeutic potential of multi-targeted siRNA inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Leveraging therapeutic potential of multi-targeted siRNA inhibitors.
@en
Leveraging therapeutic potential of multi-targeted siRNA inhibitors.
@nl
type
label
Leveraging therapeutic potential of multi-targeted siRNA inhibitors.
@en
Leveraging therapeutic potential of multi-targeted siRNA inhibitors.
@nl
prefLabel
Leveraging therapeutic potential of multi-targeted siRNA inhibitors.
@en
Leveraging therapeutic potential of multi-targeted siRNA inhibitors.
@nl
P2093
P2860
P356
P1476
Leveraging therapeutic potential of multi-targeted siRNA inhibitors.
@en
P2093
A James Mixson
David M Evans
Harry Y Yang
Patrick Y Lu
P2860
P304
P356
10.4155/FMC.09.131
P577
2009-12-01T00:00:00Z